Rachel Grossman

Prof. Rachel Grossman serves as the Vice Chairman of the Department of Neurosurgery and head of the Brain Tumor Center at at Rambam Medical Center in Israel. After completion of her neurosurgical residency at Sheba Medical Center in Israel, Prof. Grossman had joined the Surgical Neurology department at Johns Hopkins Hospital, MD, USA, where she had led a variety of research projects, including innovative approaches for brain tumor therapy. Upon her return to Israel, Prof. Grossman had joined the faculty of the neurosurgery department of the Tel-Aviv Medical Center where she served as a vice chairman and launched an active clinical and academic career with emphasis on brain tumor therapy, pituitary surgery and extended endoscopic approaches to skull base and technology development projects with various international companies. Prof. Grossman is a member of the Tumor Section of the European Association of Neurosurgical Societies (EANS) and the World Federation of Neurosurgical Societies (WFNS). Prof. Grossman serves in Executive Steering Committees and lead PI for several pharmaceuticals companies conducting multicenter international clinical studies, is a Scientific advisor for biothechnology companies, and a member of editorial boards and reviewer for leading scientific journals in her areas of expertise. Prof. Grossman's main clinical interests include surgery for complex brain tumors, including Awake Craniotomies with intra-operative cortical mapping and white matter tracking when tumors are within or near functional brain regions, endoscopic surgery for pituitary and skull base tumors and complex operations for benign tumors of the brain. Her main research areas include novel therapeutics for malignant brain tumors, including innovative immunotherapeutic approaches, combination therapies, and advanced translational imaging technologies in surgical planning.